Concepedia

Publication | Open Access

CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma

83

Citations

33

References

2012

Year

Abstract

These results establish the safety of CSPG4 mAb-based immunotherapy and suggest that CSPG4 mAb-based immunotherapy may represent a novel approach for the treatment of MM.

References

YearCitations

Page 1